 SOUTH SAN FRANCISCO, Calif., Oct. 19, 2022 GLOBE NEWSWIRE -- Aligos Therapeutics, Inc. Nasdaq: ALGS, the Company, a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today announced that it will report the companys third quarter 2022 financial results on Wednesday, November 2, 2022 after the close of the U.S. financial markets. 